Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
29,26 USD | -2,89% | -1,28% | -11,41% |
23/04 | EVOLENT HEALTH, INC. : Citigroup bevestigt koopadvies | ZM |
28/03 | EVOLENT HEALTH, INC. : Canaccord Genuity ontvangt een koopadvies | ZM |
Omzet 2024 * | 2,47 mld. 2,3 mld. | Omzet 2025 * | 2,86 mld. 2,67 mld. | Marktkapitalisatie | 3,33 mld. 3,11 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 19 mln. 17,73 mln. | Nettowinst (verlies) 2025 * | 69 mln. 64,38 mln. | EV/omzet 2024 * | 1,51 x |
Nettoschuld 2024 * | 391 mln. 365 mln. | Nettoschuld 2025 * | 272 mln. 253 mln. | EV/omzet 2025 * | 1,26 x |
K/w-verhouding 2024 * |
1.145
x | K/w-verhouding 2025 * |
60,8
x | Werknemers | 4.700 |
Dividendrendement 2024 * |
0,92% | Dividendrendement 2025 * |
0,86% | Vrij verhandelbaar | 94,57% |
Recentste transcriptie over Evolent Health, Inc.
1 dag | -2,89% | ||
1 week | -1,28% | ||
Lopende maand | -10,77% | ||
1 maand | -9,75% | ||
3 maanden | -5,67% | ||
6 maanden | +10,04% | ||
Lopend jaar | -11,41% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Seth Blackley
FOU | Founder | 45 | 01-08-11 |
Dan McCarthy
PSD | President | - | 15-09-22 |
Jessica Somers
DFI | Director of Finance/CFO | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Peter Grua
BRD | Director/Board Member | 70 | 01-02-20 |
Richard Jelinek
BRD | Director/Board Member | 59 | 08-06-23 |
Cheryl Scott
CHM | Chairman | 74 | 01-11-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.80% | 12 M€ | -.--% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 29,26 | -2,89% | 1 024 387 |
23-04-24 | 30,13 | +0,90% | 852 723 |
22-04-24 | 29,86 | +1,19% | 646 303 |
19-04-24 | 29,51 | -0,37% | 734 826 |
18-04-24 | 29,62 | -0,07% | 827 175 |
uitgestelde koers Nyse, 24 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-11,41% | 3,33 mld. | |
+4,16% | 32,41 mld. | |
+12,62% | 7,31 mld. | |
+20,05% | 3,85 mld. | |
-27,11% | 1,26 mld. | |
-34,31% | 1,12 mld. | |
+4,25% | 932 mln. | |
-23,45% | 864 mln. | |
-38,17% | 863 mln. | |
-19,40% | 702 mln. |